Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.
Saved in:
| Title: | Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors. |
|---|---|
| Authors: | Safaroghli-Azar A; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Mekonnen LB; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Lenjisa J; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Milne R; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Wang S; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia. shudong.wang@adelaide.edu.au. |
| Source: | Journal of hematology & oncology [J Hematol Oncol] 2026 Apr 06; Vol. 19 (1). Date of Electronic Publication: 2026 Apr 06. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
